A teenage girl presented with symptoms of itching and hives on contact with water for 3 years. On specific provocative testing and ruling out underlying systemic conditions, she was diagnosed with aquagenic urticaria. Following failed attempts to control her symptoms with second-generation antihistamines, she was started on monthly subcutaneous injections of the monoclonal antibody, omalizumab. The patient demonstrated significant improvement, with symptoms being well-controlled for 2 years now. She enjoys a good quality of life and can take a shower without developing itching or hives.
The role and histopathology of oral drug challenge in the evaluation of fixed drug eruptions
AbstractThis case series describes the role of oral drug challenge in the diagnosis of fixed drug eruption in the setting of polypharmacy. Practical testing guidelines are provided. The literature describing the histopathology of acute fixed drug reaction is also reviewed and compared with the findings in this series.
Urticarial vasculitis: A Complication of SMZ‐TMP therapy
AbstractRecognize that delayed hypersensitivity reactions to sulfonamides may present as urticated plaques with hyperpigmentation and purpura for which a diagnosis of urticarial vasculitis should be considered.
Utilization and timeliness of an inpatient penicillin allergy evaluation